ANACOR PHARMACEUTICALS INC COM
ANAC
ANAC was delisted on the 23rd of June, 2016.
213 hedge funds and large institutions have $4.72B invested in ANACOR PHARMACEUTICALS INC COM in 2015 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 78 increasing their positions, 65 reducing their positions, and 24 closing their positions.
154% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 24
90% more call options, than puts
Call options by funds: $73.8M | Put options by funds: $38.8M
61% more capital invested
Capital invested by funds: $2.92B → $4.72B (+$1.79B)
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
20% more funds holding
Funds holding: 177 → 213 (+36)
20% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 65
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$82.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$76.6M |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$75.9M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$66.6M |
| 5 |
Millennium Management
New York
|
+$58.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$122M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$76.9M |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$68.4M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$57M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$54.9M |
ANAC Hedge Fund Activity: Q3 2015 in Review
213 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q3 2015, worth a combined $4.72B — up 61% from $2.92B a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new ANAC positions and 24 closed out — a net gain of 37 holders — while 78 added to existing stakes and 65 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $82.2M. The largest seller was Wellington Management Group, cutting an estimated $122M.
- 213 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q3 2015, up from 177 in Q2 2015.
- Funds reported $4.72B of ANACOR PHARMACEUTICALS INC COM stock for Q3 2015, up 61% quarter-over-quarter.
- 61 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q3 2015 and 24 closed out, a net change of +37 holders.
- The largest ANACOR PHARMACEUTICALS INC COM buyer in Q3 2015 was AllianceBernstein, an estimated $82.2M added.
- The largest ANACOR PHARMACEUTICALS INC COM seller in Q3 2015 was Wellington Management Group, an estimated $122M sold.
Based on aggregated 13F filings for Q3 2015.